🕵️ MIRA Pharmaceuticals, Inc. ($MIRA)
SEC insider & ownership activity, last 12 months · CIK 1904286 · every row links its SEC filing
Over the last 12 months insiders sold $1.3M with no open-market buying against it. Aminov Erez sold $1.3M in discretionary trades (Oct). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $1.3M (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Aminov Erez | 0 | – | 1 | $1.3M | Oct 16, 2025 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 2, 2026 | filing ↗ |
| Material agreement (1.01) | May 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 13, 2026 | filing ↗ |
| Other events (8.01) | May 12, 2026 | filing ↗ |
| Other events (8.01) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Mar 3, 2026 | filing ↗ |
| Other events (8.01) | Feb 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 17, 2025 | filing ↗ |
| Other events (8.01) | Dec 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing ↗ |
| Other events (8.01) | Oct 23, 2025 | filing ↗ |
| Other events (8.01) | Oct 16, 2025 | filing ↗ |
| Other events (8.01) | Oct 15, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 29, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Sep 29, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 29, 2025 | filing ↗ |